T-cell receptor therapy achieves encouraging clinical responses in multiple myeloma
Monday, July 20, 2015 - 12:00
in Health & Medicine
Results from a clinical trial investigating a new T cell receptor therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants.